Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
04-Aug-2025 | 511 | 515.05 | 502.95 | 505.2 | 11,015 | 14,93,98,602.35 | 2,22,944 |
05-Aug-2025 | 509 | 513.7 | 499.3 | 502.35 | 7,499 | 6,63,14,704.7 | 71,053 |
06-Aug-2025 | 502.1 | 502.1 | 483.8 | 487.05 | 10,208 | 9,35,36,457.6 | 1,29,978 |
07-Aug-2025 | 486 | 500 | 477.3 | 490.8 | 17,643 | 11,68,81,064.35 | 1,19,421 |
08-Aug-2025 | 495 | 495 | 477.35 | 480.35 | 6,680 | 9,10,79,782.6 | 95,047 |
11-Aug-2025 | 485 | 515 | 477 | 479.65 | 25,845 | 36,82,03,362.55 | 1,78,262 |
12-Aug-2025 | 485 | 488.55 | 472.3 | 481.05 | 10,457 | 10,74,07,711.1 | 1,10,895 |
13-Aug-2025 | 483 | 492.35 | 482.85 | 487.6 | 4,368 | 4,37,89,298.3 | 39,208 |
14-Aug-2025 | 488.6 | 494.9 | 469 | 470.65 | 12,206 | 12,74,12,949.35 | 1,72,014 |
18-Aug-2025 | 475 | 477.65 | 463.75 | 474.5 | 10,951 | 48,73,24,119.75 | 8,36,952 |
19-Aug-2025 | 475 | 487.25 | 474 | 479.4 | 8,587 | 11,05,05,531.5 | 1,05,796 |
20-Aug-2025 | 479.6 | 484.9 | 476.8 | 480.45 | 6,477 | 11,50,38,166.95 | 1,56,351 |
21-Aug-2025 | 481 | 490 | 477.55 | 481.8 | 8,926 | 10,41,63,956.1 | 1,05,772 |
22-Aug-2025 | 481.8 | 486 | 476.15 | 480.05 | 5,167 | 5,63,96,841.65 | 58,607 |
25-Aug-2025 | 491.95 | 491.95 | 470.75 | 478.35 | 26,543 | 56,17,11,238 | 9,39,760 |
26-Aug-2025 | 478.35 | 481.5 | 469.6 | 477.1 | 15,922 | 20,36,20,705.1 | 2,84,263 |
28-Aug-2025 | 481 | 481 | 464.15 | 467.9 | 13,850 | 21,43,69,125.3 | 3,29,945 |
29-Aug-2025 | 467.9 | 469.55 | 452.2 | 454.25 | 14,716 | 10,82,69,265.5 | 1,37,401 |
The organisation is the largest CDMO serving the Indian pharmaceutical industry, with a proven track record and a broad clientele.
The IPO comprised a fresh issue of shares worth ₹680 crore and an offer-for-sale (OFS) of 1.73 crore shares, aggregating ₹1,177 crore.
The IPO consists of a fresh issue of ₹680 crore and an offer for sale (OFS) of up to 1.73 crore shares at a face value of ₹2 each.
On Monday, the business said that it had received ₹829 crore from anchor investors ahead of the public share sale subscription period.
The IPO includes a new issue of 1 Crore shares worth ₹680.00 Crore and an offer for sale of 1.73 Crore shares worth ₹1,176.74 Crore.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
